Doctors in the USA have already proven that transplants of beta cells from deceased donors and human stem cells could successfully treat type 1 diabetes. There are a few problems with this approach as you can imagine… Ethical concerns raised. There aren’t enough qualified donors to make this treatment become mainstream.
Most notoriously, with transplanted adult beta cells, the receiving patients’ immune systems end up attacking the beta cells because it sees them as a foreign invader and then patients have to live on immunosuppressor medication for the rest of their lives.
We need our immune system, so no wonder this method isn’t taking root!
In sharp contrast, our mesenchymal stem cell therapy changes all of that. It has been demonstrated that one can make a limitless supply of fully functional insulin-producing cells from stem cells.
Stem cell treatment for diabetes may involve intravenous and localized injection of up to 800 million vibrant pluripotent stromal mesenchymal stem cells (ideally 3 million MSCs / kg of body weight) as well as alternative and regenerative treatments. These stem cells have the potential to grow into new healthy pancreatic cells including beta cells.
Thus, we can generate an unlimited supply of insulin-producing beta cells to reduce or eliminate the need for insulin-replacement medication and without the need of life-long immunosuppressants (because your immune system recognizes them as your own).